Institution
Azienda Ospedaliera San Gerardo
- 5running trials
- 5closed trials
- 10,986publications (OpenAlex)
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Lung cancer1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
Registry name variants (6)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Azienda Ospedaliera San Gerardo
Monza, 20052
4 trials
Azienda Ospedaliera San Gerardo di Monza
Monza, 20090
4 trials
Azienda Ospedaliera San Gerardo di Monza
Monza MI, Lombardy 20900
1 trial
Azienda Ospedaliera San Gerardo - Monza
Monza, 20900
1 trial
NCT05429632Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Contact: Elisabetta Terruzzi, MD
ASST di Monza - Azienda Ospedaliera San Gerardo
Monza, Lombardy 20900
Azienda Ospedaliera San Gerardo (Site 0308)
Monza, Monza E Brianza 20900
Conditions
Diseases this institution publishes on or runs trials for.
- Fabry disease3 works · 0 trials
Institution data: ROR 01xf83457 (CC0-1.0)Updated 15 Nov 2026